{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:25:00Z","timestamp":1790727900157,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s13730-020-00556-9","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T18:03:05Z","timestamp":1609696985000},"page":"281-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Malignancy-associated membranous nephropathy with PLA2R double-positive for glomeruli and carcinoma"],"prefix":"10.1007","volume":"10","author":[{"given":"Itaru","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirobumi","family":"Tokuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ryuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Ishidoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wakino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"issue":"1","key":"556_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ki.2012.484","volume":"84","author":"KD Jhaveri","year":"2013","unstructured":"Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney Int. 2013;84(1):34\u201344.","journal-title":"Kidney Int"},{"issue":"1","key":"556_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","volume":"56","author":"PM Ronco","year":"1999","unstructured":"Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56(1):355\u201377.","journal-title":"Kidney Int"},{"issue":"1","key":"556_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","volume":"70","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol. 2009;70(1):39\u201358.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"556_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000364782","volume":"40","author":"N Leeaphorn","year":"2014","unstructured":"Leeaphorn N, Kue-A-Pai P, Thamcharoen N, Ungprasert P, Stokes MB, Knight EL. Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies. Am J Nephrol. 2014;40(1):29\u201335.","journal-title":"Am J Nephrol"},{"issue":"2","key":"556_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.kint.2018.10.021","volume":"95","author":"SA Bobart","year":"2019","unstructured":"Bobart SA, De Vriese AS, Pawar AS, et al. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int. 2019;95(2):429\u201338.","journal-title":"Kidney Int"},{"issue":"5","key":"556_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/modpathol.2012.207","volume":"26","author":"CP Larsen","year":"2013","unstructured":"Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26(5):709\u201315.","journal-title":"Mod Pathol"},{"issue":"4","key":"556_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ckj\/sfv049","volume":"8","author":"J L\u00f6nnbro-Widgren","year":"2015","unstructured":"L\u00f6nnbro-Widgren J, Ebefors K, M\u00f6lne J, Nystr\u00f6m J, Haraldsson B. Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy. Clin Kidney J. 2015;8(4):433\u20139.","journal-title":"Clin Kidney J"},{"issue":"6","key":"556_CR8","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2010090967","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Beck LH, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22(6):1137\u201343.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"556_CR9","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1681\/ASN.2017020178","volume":"28","author":"LH Beck","year":"2017","unstructured":"Beck LH. PLA2R and THSD7A: Disparate paths to the same disease? J Am Soc Nephrol. 2017;28(9):2579\u201389.","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"556_CR10","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMc1511702","volume":"374","author":"E Hoxha","year":"2016","unstructured":"Hoxha E, Wiech T, Stahl PR, et al. A mechanism for cancer-associated membranous nephropathy. N Engl J Med. 2016;374(20):1995\u20136.","journal-title":"N Engl J Med"},{"issue":"10","key":"556_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jclinpath-2019-205852","volume":"72","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhang M, Chen D, et al. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy. J Clin Pathol. 2019;72(10):705\u201311.","journal-title":"J Clin Pathol"},{"issue":"1","key":"556_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-019-1236-y","volume":"20","author":"S Taguchi","year":"2019","unstructured":"Taguchi S, Koshikawa Y, Ohyama S, Miyachi H, Ozawa H, Asada H. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report. BMC Nephrol. 2019;20(1):1\u20136.","journal-title":"BMC Nephrol"},{"issue":"2","key":"556_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.ajkd.2018.09.003","volume":"73","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Gong T, Rennke HG, Hayashi R. Duodenal schwannoma as a rare association with membranous nephropathy: a case report. Am J Kidney Dis. 2019;73(2):278\u201380.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"556_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/modpathol.2012.237","volume":"26","author":"CC Huang","year":"2013","unstructured":"Huang CC, Lehman A, Albawardi A, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol. 2013;26(6):799\u2013805.","journal-title":"Mod Pathol"},{"issue":"5","key":"556_CR15","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/ndt\/gfr534","volume":"27","author":"Z Qu","year":"2012","unstructured":"Qu Z, Liu G, Li J, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant. 2012;27(5):1931\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"556_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ndt\/gfg616","volume":"19","author":"H Ohtani","year":"2004","unstructured":"Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19(3):574\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"556_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1046\/j.1523-1755.1999.00369.x","volume":"55","author":"SR Holdsworth","year":"1999","unstructured":"Holdsworth SR, Kitching AR, Tipping PG. Th1 and th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int. 1999;55(4):1198\u2013216.","journal-title":"Kidney Int"},{"issue":"10","key":"556_CR18","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.2012030242","volume":"23","author":"JM Hofstra","year":"2012","unstructured":"Hofstra JM, Debiec H, Short CD, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol. 2012;23(10):1735\u201343.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"556_CR19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ki.2012.486","volume":"83","author":"D Kanigicherla","year":"2013","unstructured":"Kanigicherla D, Gummadova J, McKenzie EA, et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int. 2013;83(5):940\u20138.","journal-title":"Kidney Int"},{"issue":"July","key":"556_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.semcancer.2017.11.002","volume":"56","author":"O Sukocheva","year":"2019","unstructured":"Sukocheva O, Menschikowski M, Hagelgans A, et al. Current insights into functions of phospholipase A2 receptor in normal and cancer cells: more questions than answers. Semin Cancer Biol. 2019;56(July):116\u201327.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"556_CR21","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.18632\/oncotarget.1681","volume":"5","author":"D Vindrieux","year":"2014","unstructured":"Vindrieux D, Devailly G, Augert A, et al. Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth. Oncotarget. 2014;5(4):1004\u201313.","journal-title":"Oncotarget"},{"issue":"1","key":"556_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1937-y","volume":"15","author":"M Menschikowski","year":"2015","unstructured":"Menschikowski M, Hagelgans A, Nacke B, Jandeck C, Sukocheva O, Siegert G. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells. BMC Cancer. 2015;15(1):1.","journal-title":"BMC Cancer"},{"issue":"1","key":"556_CR23","first-page":"40","volume":"1846","author":"D Bernard","year":"2014","unstructured":"Bernard D, Vindrieux D. PLA2R1: expression and function in cancer. Biochim Biophys Acta. 2014;1846(1):40\u20134.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"556_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ygyno.2006.06.042","volume":"103","author":"M Gorovetz","year":"2006","unstructured":"Gorovetz M, Baekelandt M, Berner A, Trope CG, Davidson B, Reich R. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gynecol Oncol. 2006;103(3):831\u201340.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"556_CR25","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3109\/10428194.2010.551160","volume":"52","author":"R Amin","year":"2011","unstructured":"Amin R, Fiancette R, Bordessoule D, et al. Phospholipase A2 receptors in human leukemic blasts. Leuk Lymphoma. 2011;52(5):908\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"556_CR26","doi-asserted-by":"publisher","first-page":"e29000","DOI":"10.1371\/journal.pone.0029000","volume":"6","author":"MW Kuo","year":"2011","unstructured":"Kuo MW, Wang CH, Wu HC, Chang SJ, Chuang YJ. Soluble THSD7A is an N-glycoprotein that promotes endothelial cell migration and tube formation in angiogenesis. PLoS ONE. 2011;6(12):e29000.","journal-title":"PLoS ONE"},{"issue":"4","key":"556_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gcc.22440","volume":"56","author":"PR Stahl","year":"2017","unstructured":"Stahl PR, Hoxha E, Wiech T, Schr\u00f6der C, Simon R, Stahl RAK. THSD7A expression in human cancer. Genes Chromosom Cancer. 2017;56(4):314\u201327.","journal-title":"Genes Chromosom Cancer"},{"issue":"36","key":"556_CR28","doi-asserted-by":"publisher","first-page":"60539","DOI":"10.18632\/oncotarget.16966","volume":"8","author":"Z Hou","year":"2017","unstructured":"Hou Z, Abudureheman A, Wang L, et al. Expression, prognosis and functional role of Thsd 7a in esophageal squamous cell carcinoma of Kazakh patients Xinjiang. Oncotarget. 2017;8(36):60539\u201357.","journal-title":"Oncotarget"},{"issue":"4","key":"556_CR29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3181\/00379727-100-24736","volume":"100","author":"W Heymann","year":"1959","unstructured":"Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL. Production of nephrotic syndrome in rats by Freund\u2019s adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med Soc Exp Biol Med (New York, NY). 1959;100(4):660\u20134.","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med (New York, NY)"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-020-00556-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T14:07:18Z","timestamp":1617458838000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-020-00556-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00556-9","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"As the patient was deceased, written informed consent was obtained from the mother of the patient for publication of this case report. A copy of the written consent is available for review by the Editor of this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}